Viewing Study NCT05346861


Ignite Creation Date: 2025-12-24 @ 12:53 PM
Ignite Modification Date: 2026-01-07 @ 9:27 AM
Study NCT ID: NCT05346861
Status: UNKNOWN
Last Update Posted: 2022-04-26
First Post: 2022-04-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pyrotinib Rechallenge in Her2-positive Metastatic Breast Cancer Pretreated With Pyrotinib and Trastuzumab
Sponsor: Fudan University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module